Moelis & Co MC 深 沪
等待开盘 07-06 09:30:00 美东时间
68.55
+2.130
+3.21%
华盛通- 最 高69.30
- 今 开67.46
- 成交量 104.58万股
- 最 低 67.46
- 昨 收 66.42
- 总市值 50.98亿
- 52周最高 76.9162
- 市盈率 静 23.31
- 换手率 1.41%
- 52周最低 50.41
- 委 比 0.00%
- 总股本 7437.63万
- 历史最高 78.99
- 量 比 0.99
- 振 幅 2.77%
- 历史最低 -13.0425
- 每 手 1
- 风险率 5.31%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多MacroGenics Completes Sale of GMP Manufacturing Operations to Bora Pharmaceuticals
MacroGenics, Inc. has completed the sale of its GMP drug substance manufacturing operations to Bora Pharmaceuticals Co., Ltd. for $122.5 million. The transaction includes the transfer of MacroGenics' manufacturing site in Rockville, Maryland, and warehouse in Frederick, Maryland, along with approximately 140 employees. Bora will now handle MacroGenics' manufacturing operations and has entered into a supply agreement to support MacroGenics' intern...
07-02 13:25
Moelis names ex-Citi banker James McEwan managing director in M&A
Moelis names ex-Citi banker James McEwan managing director in M&A Moelis appointed James McEwan as a managing director in its Mergers & Acquisitions group, based in New York. McEwan will advise on strategic transactions across the energy sector, expanding the firm’s energy-focused M&A coverage. He j
06-15 20:47
AGNC Investment launches $2B ATM equity program
AGNC Investment (AGNC) has launched an at-the-market common stock offering program worth up to $2B. The firm entered into sales agreements with 14 financial institutions as agents, including Goldman S...
05-29 18:57
Moelis appoints Matt Knott managing director in London chemicals team
Moelis appoints Matt Knott managing director in London chemicals team Moelis appointed Matt Knott as a managing director in London to advise chemicals clients across EMEA. Knott brings more than 20 years of chemicals-focused investment banking experience, most recently in Lazard’s financial advisory
05-19 18:39
MacroGenics to Sell GMP Manufacturing Operations to Bora Pharmaceuticals
MacroGenics and Bora Pharmaceuticals have entered into a definitive agreement where MacroGenics will sell its GMP drug substance manufacturing operations to Bora for an upfront payment of $122.5 million. The transaction includes the transfer of MacroGenics' Maryland manufacturing site, CDMO operations, and approximately 140 employees to Bora. MacroGenics will maintain access to Bora's expanded manufacturing capabilities under a supply arrangement...
05-11 21:20
'Seattle's Holloway Hires JPMorgan, Moelis for NBA Expansion Bid' - Bloomberg
https://www.bloomberg.com/news/articles/2026-05-06/seattle-nba-expansion-team-bid-from-holloway-hires-bankers-jpmorgan-moelis
05-07 00:37
Esperion to be Acquired by ARCHIMED
Esperion Therapeutics shareholders will receive $3.16 per share in cash at closing, plus rights to up to $100 million in contingent milestone payments. The transaction values the company at up to approximately $1.1 billion. ARCHIMED, a healthcare-focused investment firm, will acquire Esperion, which specializes in cardiometabolic therapies. The deal includes two milestone payments tied to future net sales of specific products. The transaction is ...
05-01 11:00
美股5月收息策略：最高股息率超12%！塔吉特、南方电力、福特汽车等超80家公司即将分红
最高股息率超12%！塔吉特、南方电力、福特汽车等超80家公司即将分红！投资者若想赚取股息，可趁未除净适时部署，一文速览派息名单>>
05-04 19:17
Moelis & Co Files Prospectus For Offering Of Class A Common Stock; No Terms Disclosed
Class A Common StockWe may offer and sell shares of our Class A common stock from time to time, in one or more offerings, in amounts, at prices and on terms determined at the time of any such offering.We will
05-01 05:35
财报速睇 | 美驰投行 2026财年Q1营收3.20亿美元，同比增长4.3%；归母净利润0.38亿美元，同比下滑23.5%
华盛资讯5月1日讯，美驰投行公布2026财年Q1业绩，公司Q1营收3.20亿美元，同比增长4.3%，归母净利润0.38亿美元，同比下滑23.5%。
05-01 00:51
